Eco Animal Health Group PLC (LSE:EAH) Share Price

Company Profile

Business description
Eco Animal Health Group PLC is engaged in manufacturing and marketing animal health products. The company's product portfolio includes Aivlosin - macrolide antibiotic for the treatment of respiratory and enteric diseases in pigs and poultry; Ecomectin, Eco heart, Ecotraz, and Ecomintic for treatment and prevention of parasites in cattle, sheep, pigs, horses, and dogs; and Chlortetracycline and Oxytetracycline for treatment of bacterial infections in pigs, poultry and cattle. The company's geographical segments include Corporate/UK, China & Japan, North America, South & South East Asia, Latin America, Europe, and the Rest of the World. Maximum revenue for the company is generated from China and Japan.
Contact
100 High street
The Grange
Southgate
LondonN14 6BN
GBR
T: +44 2084478899
E: [email protected]
https://www.ecoanimalhealth.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2025
Employees
227

Recommended

Current operating conditions are challenging but over the long-term prospects are better.

Johannes Faul | 25 February 2025

Investors must weigh exciting growth stories against competitive dynamics and the price they are being asked to pay.

Joseph Taylor | 25 February 2025

Watching the data centre business and the debate around it, here’s what we think of Nvidia stock.

Morningstar | 25 February 2025

Index	Last price	Change	% Change
All Ordinaries	8,477.30	20.70	-0.24%
CAC 40	8,143.92	92.85	1.15%
DAX 40	22,794.11	383.84	1.71%
Dow JONES (US)	43,412.50	208.66	-0.48%
FTSE 100	8,731.46	62.79	0.72%
HKSE	23,787.93	753.91	3.27%
NASDAQ	19,089.08	62.69	0.33%
Nikkei 225	38,142.37	95.42	-0.25%
NZX 50 Index	12,452.46	145.19	1.18%
S&P 500	5,957.19	1.94	0.03%
S&P/ASX 200	8,240.70	11.20	-0.14%
SSE Composite Index	3,380.21	34.17	1.02%